OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lingguizhugan decoction dynamically regulates MAPKs and AKT signaling pathways to retrogress the pathological progression of cardiac hypertrophy to heart failure
Yao Chen, Li Lin, Cunyu Hu, et al.
Phytomedicine (2022) Vol. 98, pp. 153951-153951
Closed Access | Times Cited: 16
Yao Chen, Li Lin, Cunyu Hu, et al.
Phytomedicine (2022) Vol. 98, pp. 153951-153951
Closed Access | Times Cited: 16
Showing 16 citing articles:
Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
Siyi Yu, Hang Qian, Dawei Tian, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Siyi Yu, Hang Qian, Dawei Tian, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure
Ke Qian, Jie Tang, Yuejuan Ling, et al.
EBioMedicine (2023) Vol. 98, pp. 104863-104863
Open Access | Times Cited: 18
Ke Qian, Jie Tang, Yuejuan Ling, et al.
EBioMedicine (2023) Vol. 98, pp. 104863-104863
Open Access | Times Cited: 18
Linggui Zhugan decoction delays ventricular remodeling in rats with chronic heart failure after myocardial infarction through the Wnt/β-catenin signaling pathway
M. Yang, Haiyan Wu, Hang Qian, et al.
Phytomedicine (2023) Vol. 120, pp. 155026-155026
Closed Access | Times Cited: 16
M. Yang, Haiyan Wu, Hang Qian, et al.
Phytomedicine (2023) Vol. 120, pp. 155026-155026
Closed Access | Times Cited: 16
Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases
Jiahui Liu, Xiunan Wei, Tong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Jiahui Liu, Xiunan Wei, Tong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Upregulated LIMD1 alleviates pressure overload-induced cardiac hypertrophy via inhibits YAP1/AKT/GSK3β signaling
Fengwen Xie, Bin Yuan, Ye Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316149-e0316149
Open Access
Fengwen Xie, Bin Yuan, Ye Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316149-e0316149
Open Access
Linggui Zhugan Decoction ameliorating mitochondrial damage of doxorubicin-induced cardiotoxicity by modulating the AMPK-FOXO3a pathway targeting BTG2
Liang Kong, Yang Liu, Jiahua Wang, et al.
Phytomedicine (2025) Vol. 139, pp. 156529-156529
Closed Access
Liang Kong, Yang Liu, Jiahua Wang, et al.
Phytomedicine (2025) Vol. 139, pp. 156529-156529
Closed Access
Exploring the inflammation-related mechanisms of Lingguizhugan decoction on right ventricular remodeling secondary to pulmonary arterial hypertension based on integrated strategy using UPLC-HRMS, systems biology approach, and experimental validation
Jiayu Lv, Shuqing Shi, Zhenyue Fu, et al.
Phytomedicine (2024) Vol. 132, pp. 155879-155879
Closed Access | Times Cited: 3
Jiayu Lv, Shuqing Shi, Zhenyue Fu, et al.
Phytomedicine (2024) Vol. 132, pp. 155879-155879
Closed Access | Times Cited: 3
Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms
Junting Dai, Lulu Qiu, Yimin Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Junting Dai, Lulu Qiu, Yimin Lu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Lotus Bee Pollen Extract Inhibits Isoproterenol-Induced Hypertrophy via JAK2/STAT3 Signaling Pathway in Rat H9c2 Cells
Shuo Han, Lifu Chen, Yi Zhang, et al.
Antioxidants (2022) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 13
Shuo Han, Lifu Chen, Yi Zhang, et al.
Antioxidants (2022) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 13
Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure
Lizhen Chen, Dayun Yu, Shuang Ling, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Lizhen Chen, Dayun Yu, Shuang Ling, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics
Xu Wang, Yanhua Gao, Jia Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114066-114066
Open Access | Times Cited: 8
Xu Wang, Yanhua Gao, Jia Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114066-114066
Open Access | Times Cited: 8
Identifying biomarkers of ginseng medicines with different natures on heart failure
Linlin Liu, Mozhu Jin, Xueying Han, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118134-118134
Closed Access | Times Cited: 1
Linlin Liu, Mozhu Jin, Xueying Han, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118134-118134
Closed Access | Times Cited: 1
Chinese medicine Linggui Zhugan formula protects against diabetic kidney disease in close association with inhibition of proteinase 3-mediated podocyte apoptosis in mice
Zixuan Yi, Bei Yang, Fangyu Wan, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118650-118650
Closed Access | Times Cited: 1
Zixuan Yi, Bei Yang, Fangyu Wan, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118650-118650
Closed Access | Times Cited: 1
Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats
Mi Xiang, Xin Zhao, Yingdong Lu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 2
Mi Xiang, Xin Zhao, Yingdong Lu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 9
Open Access | Times Cited: 2
Chinese Medicine Lingui Zhugan Formula Protects Against Diabetic Kidney Disease in Close Association with Inhibition of Proteinase 3-Mediated Podocyte Apoptosis in Mice
Zixuan Yi, Bei Yang, Fangyu Wan, et al.
(2024)
Closed Access
Zixuan Yi, Bei Yang, Fangyu Wan, et al.
(2024)
Closed Access
Exploration of the pharmacological components and therapeutic mechanisms in treatment of Alzheimer's disease with Polygonati Rhizoma and its processed product using combined analysis of metabolomics, network pharmacology, and gut microbiota
Xiaojuan Liao, Hongmei Liu, Wang Zhu-xin, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35394-e35394
Open Access
Xiaojuan Liao, Hongmei Liu, Wang Zhu-xin, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35394-e35394
Open Access
